Why Did Europe Finally Choose Lecanemab for Alzheimer’s?
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart?
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart?
Japanese researchers develop a simple test for diagnosing Alzheimer’s quickly, easily, with 83% accuracy.
The European Medicines Agency (EMA) recommended approving Leqembi® (generic lecanemab) for Alzheimer’s. Originally skeptics, learn how the “Clarity AD” trial helped change their mind.
See Lady Liv, the first AI avatar born from real people’s lived experiences with dementia. Watch ‘Liv’ help those recently diagnosed, by answering questions only a peer who shares the experience of Alzheimer’s would know.
Leqembi is an FDA-Approved Alzheimer’s treatment. Hospital infusions take an hour each. 2025 is looking to see a new 15-second autoinjector version. For some, it should even work at home.
Why are some of the new anti-Alzheimer’s antibodies better than others? With the FDA’s approval of Lecanemab and Donanemab, it’s worth staying on top of this topic’s latest research.
The 2 newest Alzheimer’s drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three next ones.
A new Harvard study of 2,000 former NFL players shows one-third believe they have chronic traumatic encephalopathy (CTE), a neuropathological condition linked to repeated head trauma.
Right now, there are two FDA approved drugs to treat Alzheimer’s itself. Find out why Remternetug may soon get approval as a third, even better treatment.
Kisunla, the newest Alzheimer’s drug, is rapidly gaining acceptance around the world. Learn what it does and how to get it.
HOLIDAY TIPS: Celebrating at home or planning a visit? These important dementia-care tips can help make your holiday season the best possible.
DEMENTIA TEST + INSTRUCTIONS:
The RUDAS Dementia Test is brief, effective and free. It works well for most people. (It performs even better than other quick tests for people with cultural barriers, low education levels, or when English is not one’s first language.)
Easy golfing is great for people with dementia. It offers opportunities to socialize and be active, without memory or athletic constraints. See how one club integrated golf into the routine of a family living with dementia. Learn about an easy-to-set-up indoor/outdoor home golfing kit.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
If you couldn’t see your mashed potatoes, you probably wouldn’t eat them. That’s why what “The Red Plate Study” found was astonishing! Alzheimer’s patients eating from red plates consumed 25 percent more food than those eating from white plates. Find out why.
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor